New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Bicycle Therapeutics plc
BCYC
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

843M

Biotechnology

Next Earning date - 18 Feb 2025

843M

Biotechnology

Next Earning date - 18 Feb 2025

12.21USD

Shape-0.40 ( -3.17%)
Market Closed (as of Feb 08, 00:58 EDT)
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

-67%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

57%

Quote Panel

Shape
Updated February 10, 2025
1W -5.51 % 1M -19.66 % 3M -49.92 % 1Y -30.08 %

Key Metrics

Shape
  • Market Cap

    842.69M


  • Shares Outstanding

    69.02M


  • Share in Float

    65.57M


  • Dividende

    0


  • Earning Date

    18 Feb 2025


  • Price Target

    12.21


  • Average Volume

    562325


  • Beta

    0.892


  • Range

    12.17-28.67


  • Industry

    Biotechnology


  • Website

    https://www.bicycletherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

BCYC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$32M

Shape1090%

2025-Revenue

$3.55

Shape-380%

2025-EPS

$32M

Shape48%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

26.00(112.94%)

Number of analyst

1

Last analyst upgrade/downgrade

RBC Capital

initialise

Previous: Not converted

2024-09-05

Now: Outperform

B. Riley

downgrade

Previous: Not converted

2024-08-07

Now: Neutral

Maxim Group

initialise

Previous: Not converted

2023-09-12

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-1.01
vs -0.63

Q1.23

arrow
arrow

N/A

-1.30
vs -0.93

Q2.23

arrow
arrow

N/A

-1.41
vs -0.90

Q3.23

arrow
arrow

N/A

-1.26
vs -0.96

Q4.23

arrow
arrow

N/A

-1.16
vs -1.01

Q1.24

arrow
arrow

N/A

-0.62
vs -1.30

Q2.24

arrow
arrow

N/A

-0.77
vs -1.41

Q3.24

arrow
arrow

N/A

-0.74
vs -1.26

Q4.24

arrow
arrow

N/A

-0.86
vs -1.16

Q1.25

arrow
arrow

N/A

-0.86
vs -0.62

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-16%

3.2M  vs 3.8M

Q1.23

arrow
arrow

+27%

4.9M  vs 3.9M

Q2.23

arrow
arrow

+160%

11.4M  vs 4.4M

Q3.23

arrow
arrow

+76%

5.4M  vs 3M

Q4.23

arrow
arrow

+67%

5.3M  vs 3.2M

Q1.24

arrow
arrow

+299%

19.5M  vs 4.9M

Q2.24

arrow
arrow

-18%

9.4M  vs 11.4M

Q3.24

arrow
arrow

-50%

2.7M  vs 5.4M

Q4.24

arrow
arrow

+2%

5.4M  vs 5.3M

Q1.25

arrow
arrow

-65%

6.9M  vs 19.5M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-11%

-0.11
vs -0.10

Q1.23

arrow
arrow

-16%

-0.16
vs -0.11

Q2.23

arrow
arrow

-19%

-0.19
vs -0.16

Q3.23

arrow
arrow

-12%

-0.12
vs -0.19

Q4.23

arrow
arrow

-13%

-0.13
vs -0.12

Q1.24

arrow
arrow

-7%

-0.07
vs -0.13

Q2.24

arrow
arrow

-5%

-0.05
vs -0.07

Q3.24

arrow
arrow

-6%

-0.06
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

92

92
vs 77

19%

Q1.23

arrow
arrow

97

97
vs 92

5%

Q2.23

arrow
arrow

89

89
vs 97

-8%

Q3.23

arrow
arrow

105

105
vs 89

18%

Q4.23

arrow
arrow

108

108
vs 105

3%

Q1.24

arrow
arrow

97

97
vs 108

-10%

Q2.24

arrow
arrow

110

110
vs 97

13%

Q3.24

arrow
arrow

110

110
vs 110

NA

Earnings Growth

Latest News